• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population.作者更正：来自大量真实世界人群的NTRK1/2/3融合阳性肿瘤的基因组背景。
NPJ Precis Oncol. 2021 Sep 17;5(1):86. doi: 10.1038/s41698-021-00222-y.
2
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population.来自大量真实世界人群的NTRK1/2/3融合阳性肿瘤的基因组背景。
NPJ Precis Oncol. 2021 Jul 20;5(1):69. doi: 10.1038/s41698-021-00206-y.
3
Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.NTRK1 融合作为 EGFR+ NSCLC 对 EGFR TKI 耐药的机制证据：来自中国肺癌患者 NTRK1 融合大规模调查的结果。
Clin Lung Cancer. 2020 May;21(3):247-254. doi: 10.1016/j.cllc.2019.09.004. Epub 2019 Sep 26.
4
Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.儿科 NTRK 融合性间质肿瘤的临床病理特征。
Diagn Pathol. 2020 Sep 21;15(1):114. doi: 10.1186/s13000-020-01031-w.
5
Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.在因治疗性放疗引发的人类甲状腺肿瘤中寻找神经营养酪氨酸激酶受体1原癌基因重排。
Br J Cancer. 2000 Jan;82(2):308-14. doi: 10.1054/bjoc.1999.0920.
6
NTRK1 fusions for the therapeutic intervention of Korean patients with colon cancer.用于韩国结肠癌患者治疗干预的NTRK1融合基因
Oncotarget. 2016 Feb 16;7(7):8399-412. doi: 10.18632/oncotarget.6724.
7
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.恩曲替尼治疗晚期或转移性 NTRK 融合阳性实体瘤患者的疗效：三项 I/II 期临床试验的整合分析。
Lancet Oncol. 2020 Feb;21(2):271-282. doi: 10.1016/S1470-2045(19)30691-6. Epub 2019 Dec 11.
8
Foretinib Overcomes Entrectinib Resistance Associated with the G667C Mutation in Fusion-Positive Tumor Cells in a Brain Metastasis Model.福替替尼克服脑转移模型中融合阳性肿瘤细胞中 G667C 突变相关的恩曲替尼耐药性。
Clin Cancer Res. 2018 May 15;24(10):2357-2369. doi: 10.1158/1078-0432.CCR-17-1623. Epub 2018 Feb 20.
9
A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.BRAF、ALK和NTRK1融合性Spitzoid肿瘤的形态学与分子特征比较
Am J Surg Pathol. 2017 Apr;41(4):491-498. doi: 10.1097/PAS.0000000000000761.
10
NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.切尔诺贝利反应堆事故后儿童甲状腺乳头状癌中的NTRK1重排
Int J Cancer. 1999 Mar 15;80(6):842-7. doi: 10.1002/(sici)1097-0215(19990315)80:6<842::aid-ijc7>3.0.co;2-z.

引用本文的文献

1
Larotrectinib Compared With Real-World Non-Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer.拉罗替尼与原肌球蛋白受体激酶融合癌患者的真实世界非原肌球蛋白受体激酶抑制剂疗法的比较
JCO Precis Oncol. 2025 Apr;9:e2400500. doi: 10.1200/PO-24-00500. Epub 2025 Apr 23.
2
Digestive cancers: mechanisms, therapeutics and management.消化系统癌症：机制、治疗方法与管理
Signal Transduct Target Ther. 2025 Jan 15;10(1):24. doi: 10.1038/s41392-024-02097-4.
3
The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions.肺癌的基因分析与临床治疗：当前进展与未来方向
Cancers (Basel). 2024 Aug 19;16(16):2882. doi: 10.3390/cancers16162882.

Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population.

作者信息

Westphalen C B, Krebs M G, Le Tourneau C, Sokol E S, Maund S L, Wilson T R, Jin D X, Newberg J Y, Fabrizio D, Veronese L, Thomas M, de Braud F

机构信息

Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.

Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

出版信息

NPJ Precis Oncol. 2021 Sep 17;5(1):86. doi: 10.1038/s41698-021-00222-y.

DOI:10.1038/s41698-021-00222-y
PMID:34535754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8448774/
Abstract
摘要